Meribank Biotech Co., Ltd reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was TWD 103.06 million compared to TWD 78.67 million a year ago. Net loss was TWD 59.8 million compared to TWD 50.73 million a year ago.

Basic loss per share from continuing operations was TWD 0.95 compared to TWD 0.81 a year ago.